Retrospective cohort analysis of the safety of outpatient parenteral antimicrobial therapy (OPAT) in an academic hospital

Retrospective cohort analysis of the safety of outpatient parenteral antimicrobial therapy (OPAT) in an academic hospital

Background: Although many infectious conditions can be safely treated with oral antimicrobials, select circumstances require parenteral antimicrobial therapy. Benefits of OPAT include prevention of hospital-associated conditions and significant cost savings. However, risks of OPAT include adverse dr...

Full description

Bibliographic Details
Main Authors:	Kaylyn Billmeyer, Alison Galdys, Susan Kline, Elizabeth Hirsch, Jennifer Ross, Michael Evans
Format:	Article
Language:	English
Published:	Cambridge University Press 2022-07-01
Series:	Antimicrobial Stewardship & Healthcare Epidemiology
Online Access:	https://www.cambridge.org/core/product/identifier/S2732494X2200170X/type/journal_article

Similar Items

Predictors of adverse safety events and unscheduled care among an outpatient parenteral antimicrobial therapy (OPAT) patient cohort
by: Kaylyn N. Billmeyer, et al.
Published: (2023-06-01)

Outpatient parenteral antimicrobial therapy (OPAT) in a safety-net hospital: Opportunities for improvement
by: Rory Bouzigard, et al.
Published: (2023-06-01)

Effectiveness of outpatient parenteral antimicrobial therapy (OPAT) for patients with cranial infection
by: Fatma Kilinc, et al.
Published: (2023-10-01)

Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis
by: Jacky Tu, et al.
Published: (2023-09-01)

Evaluate the Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) Program in Saudi Arabia: A Retrospective Study
by: Haneen J. Al Shareef, et al.
Published: (2022-03-01)

Cost evaluation of a nurse coordinated outpatient parenteral antimicrobial therapy (OPAT) program
by: Huiwen Deng, et al.
Published: (2023-01-01)

Experiences in outpatient parenteral antimicrobial therapy (OPAT): Barriers and challenges from the front lines
by: Nicole Ng, et al.
Published: (2021-01-01)

Paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): An e-survey of the experiences of parents and clinicians.
by: Bernie Carter, et al.
Published: (2021-01-01)

Decreased hospital readmissions after programmatic strengthening of an outpatient parenteral antimicrobial therapy (OPAT) program
by: Gaurav Agnihotri, et al.
Published: (2023-01-01)

Assessment of risk factors associated with outpatient parenteral antimicrobial therapy (OPAT) complications: A retrospective cohort study
by: Christina M. Kaul, et al.
Published: (2022-01-01)

Outpatient parenteral antimicrobial therapy (OPAT) for aortic vascular graft infection; a five-year retrospective evaluation
by: Niamh Allen, et al.
Published: (2021-07-01)

Outcomes of outpatient parenteral antimicrobial therapy (OPAT) for urinary tract infections – A single center retrospective cohort study
by: Sadia Shakoor, et al.
Published: (2023-01-01)

Clinic- and Hospital-Based Home Care, Outpatient Parenteral Antimicrobial Therapy (OPAT) and the Evolving Clinical Responsibilities of the Pharmacist
by: Toni Docherty, et al.
Published: (2020-12-01)

A broader view on outpatient parenteral antibiotic therapy (OPAT) stewardship
by: Danielle Hess, et al.
Published: (2022-01-01)

Palliative outpatient parenteral antimicrobial therapy (OPAT): A single center experience and systematic scoping review
by: Oyewole Chris Durojaiye, et al.
Published: (2022-11-01)

Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center
by: Taylor M. Epperson, et al.
Published: (2023-01-01)

Successful treatment of multiple Nocardia farcinica cerebral abscesses using an outpatient parenteral antimicrobial therapy (OPAT) service
by: Alberto San Francisco, et al.
Published: (2020-04-01)

Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center – ADDENDUM
by: Taylor M. Epperson, et al.
Published: (2023-01-01)

Clinical Effectiveness of Continuous Infusion Flucloxacillin in the Outpatient Parenteral Antimicrobial Therapy (OPAT) Setting in a UK Hospital: A Service Evaluation
by: Annette Margaret Clarkson, et al.
Published: (2024-02-01)

Rate of broad-spectrum antibiotic overuse in patients receiving outpatient parenteral antibiotic therapy (OPAT)
by: Jessa R. Brenon, et al.
Published: (2021-01-01)

Impact of a pharmacy resident on a transitions of care rotation for inpatients enrolled in an outpatient parenteral antimicrobial therapy (OPAT) program
by: Rachel S. Britt, et al.
Published: (2023-01-01)

Implementation of a Collaborated Antimicrobial Stewardship Program and Outpatient Parenteral Antimicrobial Therapy (OPAT) Unit-driven Monoclonal Antibody Therapy Program for COVID-19 at an NYC Hospital
by: George D. Rodriguez, et al.
Published: (2022-05-01)

PICC Your Battles: Considering the Appropriateness of Peripherally Inserted Central Catheter (PICC) Lines for Outpatient Parenteral Antimicrobial Therapy (OPAT) in Injection Drug Users (IDUs)
by: Maxime Jasmine Billick
Published: (2017-06-01)

Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections
by: Laura C. Fanucchi, et al.
Published: (2022-07-01)

Outpatient parenteral antimicrobial therapy in Brazil
by: Priscila R Oliveira, et al.
Published: (2023-06-01)

Safety of Nurse- and Self-Administered Paediatric Outpatient Parenteral Antimicrobial Therapy
by: Shanthy Sriskandarajah, et al.
Published: (2020-10-01)

Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection
by: Fatma Kilinc, et al.
Published: (2023-04-01)

Recommendations for outpatient parenteral antimicrobial therapy in Brazil
by: Priscila R. Oliveira, et al.
Published: (2017-11-01)

Outpatient Parenteral Antimicrobial Therapy for Infective Endocarditis—Model of Care
by: Dylan Rajaratnam, et al.
Published: (2023-02-01)

Patient outcomes following home-based outpatient parenteral antimicrobial therapy and facility-based outpatient parenteral antimicrobial therapy: a systematic review and meta-analysis
by: Shinya Hasegawa, et al.
Published: (2023-01-01)

Facilitating OPAT in rural areas
by: Meera Mehta, et al.
Published: (2023-11-01)

Exploring the advancements of Australian OPAT
by: Tony Lai, et al.
Published: (2023-09-01)

Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study
by: Victoria Huang, et al.
Published: (2018-08-01)

Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety
by: Al Alawi S, et al.
Published: (2015-08-01)

A review of evidence, antimicrobial stability, and feasibility considerations for OPAT continuous infusion
by: Amy L. Van Abel, et al.
Published: (2023-08-01)

Stability of antimicrobial agents in an elastomeric infusion pump used for outpatient parenteral antimicrobial therapy
by: Mutsumi Akahane, et al.
Published: (2021-02-01)

Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy
by: Tanner M. Johnson, et al.
Published: (2023-08-01)

Assessment of risk factors associated with outpatient parenteral antimicrobial therapy complications
by: Christina Kaul, et al.
Published: (2022-07-01)

Dalbavancin as an alternative to traditional outpatient parenteral antimicrobial therapy for deep gram-positive infections – an observational, retrospective review
by: Hongkai Bao, et al.
Published: (2024-04-01)

Shortening duration of ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections: A retrospective study.
by: Doug L Fink, et al.
Published: (2019-01-01)